SIMULATION MODELING OF OUTCOMES AND COST EFFECTIVENESS
- 1 August 2000
- journal article
- review article
- Published by Elsevier in Hematology/Oncology Clinics of North America
- Vol. 14 (4) , 925-938
- https://doi.org/10.1016/s0889-8588(05)70319-1
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- SERIAL PROSTATE SPECIFIC ANTIGEN SCREENING FOR PROSTATE CANCER: A COMPUTER MODEL EVALUATES COMPETING STRATEGIESJournal of Urology, 1999
- Cancer Surveillance Series: Interpreting Trends in Prostate Cancer Part III: Quantifying the Link Between Population Prostate-Specific Antigen Testing and Recent Declines in Prostate Cancer MortalityJNCI Journal of the National Cancer Institute, 1999
- Screening for ovarian cancer: a pilot randomised controlled trialThe Lancet, 1999
- The MISCAN-COLON Simulation Model for the Evaluation of Colorectal Cancer ScreeningComputers and Biomedical Research, 1999
- Assessing uncertainty in microsimulation modelling with application to cancer screening interventionsStatistics in Medicine, 1998
- Modelling in Ecomomic Evaluation: An Unavoidable Fact of LifeHealth Economics, 1997
- Economic foundations of cost-effectiveness analysisJournal of Health Economics, 1997
- Prostate cancer and computer models: Background, limitations, and potentialUrologic Oncology: Seminars and Original Investigations, 1996
- Economic Analysis Alongside Clinical Trials: Revisiting the Methodological IssuesInternational Journal of Technology Assessment in Health Care, 1991
- The Markov Process in Medical PrognosisMedical Decision Making, 1983